GNPX
Genprex Inc
NASDAQ: GNPX · HEALTHCARE · BIOTECHNOLOGY
$0.98
+12.07% today
Updated 2026-04-30
Market cap
$8.41M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-17.40
Dividend yield
—
52W range
$1 – $55
Volume
1.1M
Genprex Inc (GNPX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |